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Abstract We present a patient with poikiloderma, severe os-
teoporosis and a mild intellectual disability. At the age of
9 years, this patient was proposed to suffer from a novel dis-
ease entity designated as calcinosis cutis, osteoma cutis,
poikiloderma and skeletal abnormalities (COPS) syndrome.
At the age of 35, he was diagnosed with Hodgkin’s lympho-
ma. Recently, biallelic pathogenic variants in the RECQL4
gene were detected (c.1048_1049delAG and c.1391-1G>A),
confirming a diagnosis of Rothmund-Thomson syndrome
(RTS). In the brother of this patient, who had a milder pheno-
type, a similar diagnosis was made.
Conclusion: We conclude that COPS syndrome never existed
as a separate syndrome entity. Instead, osteoma cutis may be
regarded as a novel feature of RTS, whereas mild intellectual dis-
ability and lymphoma may be underreported parts of the
phenotype.
What is new:
•Osteoma cutis was not a known feature in Rothmund-Thomson patients.




• Patients with RTS frequently show chromosomal abnormalities like, e.g.
mosaic trisomy 8.
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2016
Arnold P. Oranje has passed away shortly before submitting the final
version of the paper.
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Abbreviations
BMD Bone marrow density
COPS syndrome Calcinosis cutis, osteoma cutis,
poikiloderma and skeletal abnormalities
DNA Deoxyribonucleic acid
FISH Fluorescent in situ hybridisation
ID Intellectual disability
LSI MYC Locus-specific identifier (LSI) MYC,
2 FISH probes used to visualise locus
8q24 on chromosome 8
RECQL4 DNA helicase, RECQ-like, type 4
RTS Rothmund-Thomson syndrome
Case description
A 34-year-old man with dysmorphic features, osteoporosis and
recurrent fragility fractures with non-union was referred to the
department of clinical genetics. At age 9, a clinical diagnosis of
calcinosis cutis, osteoma cutis, poikiloderma and skeletal abnor-
malities (COPS syndrome) was made and reported in this jour-
nal [11]. In summary, he had dysmaturity (birth weight 2400 g at
40 weeks gestational age) and severe diarrhoea requiring paren-
teral feeding. At the age of 3, he suffered frommeningitis due to
mumps infection. Furthermore, at the age of 4, subcutaneous
tumours, osteomas, with a maximal diameter of 3 cm were
removed from the ankles, knees and forehead. Skeletal abnor-
malities were observed with hypoplastic patellae and delayed
bone maturation. At the age of 15 years, a diagnosis of coeliac
disease was made for which he was started on a diet and vitamin
D supplementation. He suffered frommultiple fragility fractures
of both the tibiae, the right elbow, the left patella and the meta-
tarsal bone Vof his right foot, complicated by pseudo arthroses.
A bone mass density measurement was performed at age 27,
showing a T-score of −2.6 femur and 2.4 lumbar vertebrae,
consistent with a diagnosis of osteoporosis. Treatment with
alendronate was initiated and while on treatment his bone mass
increased and no fractures occurred. Treatment was
discontinued at the age of 30 and at age 34. He suffered from
a mild intellectual disability for which he attended special edu-
cational programs.
At age 34, he was referred to our hospital for a second opin-
ion regarding his osteoporosis and non-union of a tibia fracture.
Physical examination showed a slender man with a short stature
(height 167 cm, (−2.1 SDS), with a saddle nose, absence of
eyelashes and eyebrows and facial poikiloderma, (Fig. 1). He
had sparse hair on the scalp, with two spots of alopecia areata
and multiple small hyperpigmented macules on the trunk and
arms. He had small but normal hands (Fig. 2); at the right foot, a
partial 2–3 syndactyly of the right foot was observed.
His 5 years older brother has a milder phenotype, with a
similar physical appearance and a mild intellectual disability.
He was diagnosed with osteopenia and recurrent fragility frac-
tures with non-union, but not with celiac disease (Table 1).
Their parents were non-consanguineous.
Altogether, this presentation was compatible with a clinical di-
agnosisofRothmund-Thomsonsyndrome(RTS,OMIM268400).
Cytogenetic testing at the age of 13 showed a normal male
karyotype in a total of 50 analysed nuclei without signs of
Fig. 1 Facial features at age 34. Note: absent eye brows and eye lashes,
small nose
Fig. 2 Hands at age 34. Note: relatively small hands, with small though
normally shaped nails, normal thumbs
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chromosomal instability, while a CytoScan HD Array
(Affymetrix) at the age of 34 showed a slight excess of chro-
mosome 8q, suggestive for a mosaic chromosome 8q duplica-
tion (presumably between 12 and 18%). Subsequently,
karyotyping and FISH analysis were performed on cultured
lymphocytes from both brothers, showing a mosaicism for
trisomy 8, isochromosome 8q and a normal karyotype
(Table 1). Sanger sequencing of the RECQL4 gene (OMIM
603780) showed two compound heterozygous recurrent path-
ogenic mutations in both brothers: one frame shift mutation:
Table 1 Clinical features in our patient and his brother compared with the frequencies of these features among previously reported Rothmund-
Thomson patients
Our patient Brother of the patient Reported frequency of RTS featuresa
Skin
Poikiloderma + + All
Hyperpigmentation + + +
Hypopigmentation + + +
Calcinosis cutis + − Uncommon
Osteoma cutis + − −
Palmoplantar hyperkeratosis − − 30%
Photosensitivity − − +/−
Hair 50%
Sparse hair + +
Absent eyelashes + +
Sparse/absent eyebrows + +
Alopecia areata + −
Dental abnormalities + − 27–59%
Growth
Low birth weight + + +
Short stature + + +
Skeleton 68–75%
Radial ray defects − − 20%
Metaphyseal changes + − +
Osteopenia/osteoporosis + + +
Small patellae + − +
Ocular lesions
Cataract − − 10–50%
Gastrointestinal features 17%
Oesophageal or pyloric stenosis + −
Feeding problems + −
Chronic emesis/diarrhoea + −
Hematologic abnormalities Hodgkin’s lymphoma − Occasionally
Cancer
Osteosarcoma − − 30%
Skin cancer − − 5%
Lymphoma + − Two casesb
Neurocognitive development No specific data available
Mild intellectual disability + +





Mosaic isochromosome 2, 7 or 8
RECQL4 gene mutations + + 66%
a Frequencies derived from [2, 8, 16, 17]
b Cases reported by Siitonen 2009 and Simon 2010 [13, 14]
c Based on interphase FISH (2 probes: LSI MYC, 8q24) on 400 lymphocytes nuclei in blood
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c.1048_1049delAG (p.(Arg350fsX21)) and one splice site
mutation c.1391-1G>A (p.(?)). Carrier testing in the parents
confirmed biallelic inheritance. Altogether, these findings
confirmed the clinical diagnosis of RTS in both brothers.
One year later, the index patient was diagnosed with a stage
I Hodgkin’s lymphoma in the neck for which he was started
on three cycles of adriamycin, bleomycin, vinblastin,
darcabazin and prednisone in combination with involved node
radiation with 12 × 1.8 Gy resulting in a complete remission.
He developed fever and neutropenia after the first chemother-
apy. The neutropenia has resolved after a temporary break of
chemotherapy and treatment with antibiotics. Neutropenia did
not return after continuation of the ABVD therapy. The radio-
therapy did not lead to considerable side effects.
Discussion
In this report, we presented a case of RTS alternatively diag-
nosed as COPS. RTS is a rare autosomal recessive
genodermatosis with a distinctive phenotype, characterised
by poikiloderma, sparse hair, skeletal abnormalities and an
increased risk for osteosarcoma [8]. RTS had been considered,
but was assumed less likely, due to the absence of cataract and
photophobia, a major sign, and the presence of osteoma cutis,
whereas genetic confirmation was not possible in that period
[11]. However re-evaluation of the patient and his brother
changed the diagnosis to RTS and later the cataract was not
associated with RECQL4 mutations anymore.
The absence of the cataract makes the distinction between
the two clinical variants of RTS: the form with poikiloderma
and ocular defects, named RTSI, and poikiloderma, skeleton
defects, predisposition to cancer and RECQL4 mutations,
named RTSII, which accounts for approximately 66% of
RTS patients (Table 1). Osteoma cutis has not been described
before; calcinosis cutis has been linked to RTS [1, 4].
The RECQL4 gene on the long arm of chromosome 8
(8q24.3) codes for anATP-dependentDNAhelicase,which plays
a role in regulating DNA replication, DNA repair and chromo-
somal integrity [6, 13]. RECQL4-deficient mice show abnormal
karyotypes and aneuploidy [10], as well as defects in osteoblast
progenitors [18]. In patients with RTS, these defects in osteoblast
progenitors make them prone to osteosarcoma and low-turnover
osteoporosis with a predisposition for fracture non-union [9, 18].
Chromosomal abnormalities, like the mosaic trisomy 8 and i(8q)
have been reported in RTS patients [7]. The specific RECQL4
mutations, c.1048_1049delAG in exon 5 and c.1391-1G>A in
intron 7, were both previously reported in patients with RTS [3,
8]. One patient was reported with the exact combination of mu-
tations; contrary to our patient, this patient showed additional
humoral immune deficiency and granulomatous skin lesions [3].
Generally, intellectual disability is not considered to be a
feature of RTS [8, 13, 17]. As a consequence, the number of
RTS patients with a mild intellectual disability, like our pa-
tients, may be underestimated. Mild to moderate intellectual
disability has been reported in a small number of cases [5, 8,
15, 16]. Co-occurring features like hydrocephalus and cranio-
synostosis may have played a role in the ID [16], and in some
cases the diagnosis of RTS was not confirmed [5]. In our case,
the history of meningitis may have attributed to some part of
the intellectual disability; however, the brother was affected as
well, implying a relationship with RTS. We hypothesised that
the mosaic chromosomal abnormalities observed are respon-
sible for the development of intellectual disability. However,
the chromosomal imbalances were apparently acquired.
Additionally, mutations in RecQ DNA helicase genes may
mildly impact intellectual development, such as observed in
Bloom syndrome (OMIM 210900), a chromosomal breakage
syndrome, caused by mutations in the RECQL3 gene (OMIM
604610). Althoughmost affected individuals with Bloom syn-
drome have normal intellectual ability, many exhibit learning
disability [12]. Likewise, a relative mild intellectual disability,
such as in our patients, may be underreported in RTS patients
and considered to be normal variability of intelligence.
Modifier genes and co-morbidity may also play a role in the
variability and atypical expression with or without ID; these
may explain the phenotypic differences between the brothers.
In conclusion, we reclassify a patient with COPS as RTS
with osteoma cutis and a mild intellectual disability, refuting
COPS as a separate entity, since there were no reports in lit-
erature after 1991. To link mild intellectual disability to RTS,
more studies are needed.
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